long-acting recombinant Erwinia asparaginase JZP341
Term · Oncology and biomedicine · MLC-T-ONC-014882
A long-acting and recombinant form of asparaginase (Erwinia asparaginase; crisantaspase), with potential antineoplastic activity. Upon administration of long-acting recombinant Erwinia asparaginase JZP-341, the recombinant asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia. This depletes cancer cells of asparagine, which blocks protein synthesis and tumor cell proliferation. Asparagine is critical to protein synthesis in cancer cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase.
| Identifier | MLC-T-ONC-014882 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | long-acting recombinant Erwinia asparaginase PF745 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014882",
"term": "long-acting recombinant Erwinia asparaginase JZP341",
"field": "Oncology and biomedicine",
"definition": "A long-acting and recombinant form of asparaginase (Erwinia asparaginase; crisantaspase), with potential antineoplastic activity. Upon administration of long-acting recombinant Erwinia asparaginase JZP-341, the recombinant asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia. This depletes cancer cells of asparagine, which blocks protein synthesis and tumor cell proliferation. Asparagine is critical to protein synthesis in cancer cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase.",
"synonyms": [
"long-acting recombinant Erwinia asparaginase PF745"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/long-acting-recombinant-erwinia-asparaginase-jzp341/"
}
Record 10,295 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.